Abbott Laboratories (ABT)
NYSE: ABT · Real-Time Price · USD
134.92
+1.75 (1.31%)
Feb 21, 2025, 4:00 PM EST - Market closed
Abbott Laboratories Revenue
In the year 2024, Abbott Laboratories had annual revenue of $41.95B with 4.59% growth. Abbott Laboratories had revenue of $10.97B in the quarter ending December 31, 2024, with 7.16% growth.
Revenue (ttm)
$41.95B
Revenue Growth
+4.59%
P/S Ratio
5.62
Revenue / Employee
$367,982
Employees
114,000
Market Cap
234.01B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 41.95B | 1.84B | 4.59% |
Dec 31, 2023 | 40.11B | -3.54B | -8.12% |
Dec 31, 2022 | 43.65B | 578.00M | 1.34% |
Dec 31, 2021 | 43.08B | 8.47B | 24.47% |
Dec 31, 2020 | 34.61B | 2.70B | 8.48% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
ABT News
- 14 hours ago - Abbott Declares 405th Consecutive Quarterly Dividend - PRNewsWire
- 16 days ago - Here are the best performing dividend aristocrats stocks in 2025 - Invezz
- 17 days ago - Abbott's 'Above the Bias' Film Reveals Misconceptions Can Impact Diabetes Care - PRNewsWire
- 23 days ago - My Best Dividend Aristocrats For February 2025 - Seeking Alpha
- 25 days ago - Is There More Upside For ABT Stock After A 10% Jump In A Week? - Forbes
- 26 days ago - Abbott Laboratories: Strong Q4 Results And Bullish Outlook - Seeking Alpha
- 4 weeks ago - What Can The Dividend Kings Deliver In 2025? - Seeking Alpha
- 4 weeks ago - Why Is Abbott Stock Trading Higher On Thursday? - Benzinga